Valuation: Treace Medical Concepts, Inc.

Market Cap 298M 258M 244M 221M 415M 28.57B 418M 2.91B 1.12B 14.49B 1.12B 1.09B 46.2B P/E 2026 *
-5.38x
P/E 2027 * -5.91x
Enterprise Value 344M 298M 281M 255M 478M 32.95B 482M 3.36B 1.29B 16.71B 1.29B 1.26B 53.29B EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.73x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day-1.08%
1 week-1.08%
Current month-2.55%
1 month-4.38%
3 months+16.84%
6 months+213.70%
Current year+86.94%
1 week 4.31
Extreme 4.31
4.66
1 month 4.25
Extreme 4.25
5.01
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.61
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 30/06/2013
Director of Finance/CFO 56 31/08/2020
Chief Tech/Sci/R&D Officer - 28/02/2022
Director TitleAgeSince
Chairman 54 19/05/2025
Director/Board Member 65 19/11/2020
Director/Board Member 68 19/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Buy

Chief Executive Officer

11,000 0.0170%
09/08/26 Tax

Chief Financial Officer

-37,102 0.0572%
09/08/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%-1.08%-36.57%-68.15% 298M
-0.45%-0.26%+21.02%+19.00% 12.54B
+0.63%+0.59%+13.35%+18.56% 6.63B
+0.18%-5.62% - - 6.19B
+0.55%+0.31%+23.32%+12.21% 5.56B
-1.23%+2.35%-17.58%+38.98% 5.08B
+2.24%+1.64%-32.72%-24.87% 3.87B
-0.43%-4.15%+26.97%-16.32% 1.88B
-2.13%-0.17%-0.83%+191.93% 1.77B
+0.49%-0.65%+47.54%-17.30% 1.61B
Average -0.12%-1.14%+4.94%+17.12% 4.54B
Weighted average by Cap. +0.02%-1.43%+9.70%+20.18%

Financials

2026 *2027 *
Net sales 207M 180M 170M 154M 289M 19.9B 291M 2.03B 780M 10.09B 779M 762M 32.18B 222M 192M 182M 164M 309M 21.27B 311M 2.17B 834M 10.78B 833M 814M 34.4B
Net income -55.26M -47.87M -45.27M -40.98M -76.91M -5.3B -77.49M -540M -208M -2.69B -208M -203M -8.57B -51.01M -44.19M -41.78M -37.83M -70.99M -4.89B -71.53M -499M -192M -2.48B -192M -187M -7.91B
Net Debt 45.67M 39.56M 37.4M 33.86M 63.56M 4.38B 64.03M 446M 172M 2.22B 172M 168M 7.08B 86.44M 74.87M 70.8M 64.1M 120M 8.29B 121M 845M 325M 4.2B 325M 317M 13.41B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
15/09/26 US$4.580 -1.08% 161,521
14/09/26 US$4.630 +2.66% 230,244
11/09/26 US$4.510 +3.68% 147,536
10/09/26 US$4.350 -3.97% 223,501
09/09/26 US$4.530 -2.16% 113,556
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.580USD
Average target price
5.500USD
Spread / Average Target
+20.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!